- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZFY: 2-{2-[(cyclopropanesulfonyl)amino]-1,3-thiazol-4-yl}-2-methyl-N-{5-[6-(trifluoromethyl)pyrazin-2-yl]pyridin-2-yl}propanamide(Non-covalent)
- 4 x GLN: GLUTAMINE(Non-covalent)
GLN.2: 15 residues within 4Å:- Chain A: G.371, G.372, F.373, G.374, C.399, L.400, Q.403, E.423, F.424, R.479, H.480, R.481, F.482, Q.524, H.526
12 PLIP interactions:10 interactions with chain A, 2 Ligand-Ligand interactions- Hydrophobic interactions: A:F.373, A:L.400
- Hydrogen bonds: A:G.372, A:G.372, A:L.400, A:Q.403, A:H.480, A:R.481, A:F.482, A:H.526, Q.2, Q.2
GLN.8: 15 residues within 4Å:- Chain B: G.371, G.372, F.373, G.374, C.399, L.400, Q.403, E.423, F.424, R.479, H.480, R.481, F.482, Q.524, H.526
12 PLIP interactions:11 interactions with chain B, 1 Ligand-Ligand interactions- Hydrophobic interactions: B:F.373, B:L.400
- Hydrogen bonds: B:G.372, B:G.372, B:L.400, B:Q.403, B:Q.403, B:H.480, B:R.481, B:F.482, B:H.526, Q.8
GLN.10: 15 residues within 4Å:- Chain C: G.371, G.372, F.373, G.374, C.399, L.400, Q.403, E.423, F.424, R.479, H.480, R.481, F.482, Q.524, H.526
12 PLIP interactions:11 interactions with chain C, 1 Ligand-Ligand interactions- Hydrophobic interactions: C:F.373, C:L.400
- Hydrogen bonds: C:G.372, C:G.372, C:L.400, C:Q.403, C:Q.403, C:H.480, C:R.481, C:F.482, C:H.526, Q.10
GLN.16: 15 residues within 4Å:- Chain D: G.371, G.372, F.373, G.374, C.399, L.400, Q.403, E.423, F.424, R.479, H.480, R.481, F.482, Q.524, H.526
12 PLIP interactions:10 interactions with chain D, 2 Ligand-Ligand interactions- Hydrophobic interactions: D:F.373, D:L.400
- Hydrogen bonds: D:G.372, D:G.372, D:L.400, D:Q.403, D:H.480, D:R.481, D:F.482, D:H.526, Q.16, Q.16
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 3 residues within 4Å:- Chain A: K.193, K.229
- Ligands: UTP.4
No protein-ligand interaction detected (PLIP)MG.5: 3 residues within 4Å:- Chain B: K.193, K.229
- Ligands: UTP.6
No protein-ligand interaction detected (PLIP)MG.11: 3 residues within 4Å:- Chain C: K.193, K.229
- Ligands: UTP.12
No protein-ligand interaction detected (PLIP)MG.13: 3 residues within 4Å:- Chain D: K.193, K.229
- Ligands: UTP.14
No protein-ligand interaction detected (PLIP)- 4 x UTP: URIDINE 5'-TRIPHOSPHATE(Non-covalent)
UTP.4: 21 residues within 4Å:- Chain A: Q.192, K.193, T.194, K.195, Q.198, K.229
- Chain B: I.11, S.12, K.16, K.38, I.39, D.40, P.41, Y.42, H.55, G.148, G.149, E.155
- Chain D: T.110, Q.112
- Ligands: MG.3
16 PLIP interactions:9 interactions with chain A, 7 interactions with chain B- Hydrogen bonds: A:T.194, A:K.195, A:K.195, A:Q.198, B:S.12, B:S.12, B:K.38, B:P.41, B:H.55, B:G.149
- Salt bridges: A:K.193, A:K.193, A:K.195, A:K.195, A:K.229
- Hydrophobic interactions: B:D.40
UTP.6: 21 residues within 4Å:- Chain A: I.11, S.12, K.16, K.38, I.39, D.40, P.41, Y.42, H.55, G.148, G.149, E.155
- Chain B: Q.192, K.193, T.194, K.195, Q.198, K.229
- Chain C: T.110, Q.112
- Ligands: MG.5
15 PLIP interactions:6 interactions with chain A, 9 interactions with chain B- Hydrophobic interactions: A:D.40
- Hydrogen bonds: A:S.12, A:K.38, A:P.41, A:H.55, A:G.149, B:T.194, B:K.195, B:K.195, B:Q.198
- Salt bridges: B:K.193, B:K.193, B:K.195, B:K.195, B:K.229
UTP.12: 21 residues within 4Å:- Chain B: T.110, Q.112
- Chain C: Q.192, K.193, T.194, K.195, Q.198, K.229
- Chain D: I.11, S.12, K.16, K.38, I.39, D.40, P.41, Y.42, H.55, G.148, G.149, E.155
- Ligands: MG.11
15 PLIP interactions:9 interactions with chain C, 6 interactions with chain D- Hydrogen bonds: C:T.194, C:K.195, C:K.195, C:Q.198, D:S.12, D:K.38, D:P.41, D:H.55, D:G.149
- Salt bridges: C:K.193, C:K.193, C:K.195, C:K.195, C:K.229
- Hydrophobic interactions: D:D.40
UTP.14: 21 residues within 4Å:- Chain A: T.110, Q.112
- Chain C: I.11, S.12, K.16, K.38, I.39, D.40, P.41, Y.42, H.55, G.148, G.149, E.155
- Chain D: Q.192, K.193, T.194, K.195, Q.198, K.229
- Ligands: MG.13
16 PLIP interactions:9 interactions with chain D, 7 interactions with chain C- Hydrogen bonds: D:T.194, D:K.195, D:K.195, D:Q.198, C:S.12, C:S.12, C:K.38, C:P.41, C:H.55, C:G.149
- Salt bridges: D:K.193, D:K.193, D:K.195, D:K.195, D:K.229
- Hydrophobic interactions: C:D.40
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lynch, E.M. et al., Structural basis for isoform-specific inhibition of human CTPS1. Proc.Natl.Acad.Sci.USA (2021)
- Release Date
- 2021-10-13
- Peptides
- CTP synthase 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZFY: 2-{2-[(cyclopropanesulfonyl)amino]-1,3-thiazol-4-yl}-2-methyl-N-{5-[6-(trifluoromethyl)pyrazin-2-yl]pyridin-2-yl}propanamide(Non-covalent)
- 4 x GLN: GLUTAMINE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x UTP: URIDINE 5'-TRIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lynch, E.M. et al., Structural basis for isoform-specific inhibition of human CTPS1. Proc.Natl.Acad.Sci.USA (2021)
- Release Date
- 2021-10-13
- Peptides
- CTP synthase 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
E